Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# Glaukos Corporation (GKOS)

Glaukos Corporation's Epioxa receives FDA approval and Q3 earnings beat expectations, but market caution and recent price drops are overshadowing the positive news.

### About Glaukos Corporation
Glaukos Corporation is a healthcare company specializing in ophthalmic medical devices and therapies.  
Glaukos Corporation uses the ticker $GKOS for trading. Listed in the [Stocks](/list/stocks) category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights
- Glaukos Corporation (GKOS) trading volume is up XXXXXX% from the previous week.
- Glaukos Corporation (GKOS) social dominance is up XXXXXX% from the previous X months.
- Glaukos Corporation Price hit a 52-Week high of $XXXXXX for the hour
- Glaukos Corporation Price hit an all time of $XXXXXX for the hour

### Price: $XXXXXX
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$gkos/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/$gkos/time-series/close.tsv)  
The stock is trading lower due to broader market caution and recent price drops, which are overshadowing positive catalysts like FDA approval and strong Q3 earnings. Analyst upgrades suggest potential upside, but current sentiment is cautious.  

24-Hour: -XXXX%
7-Day: XXXX%
30-Day: XXXXX%

1-Year High: $XXXXXX on 2025-01-23  
1-Year Low: $XXXXX on 2025-10-24  
  
  
### AltRank: XXXXX
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$gkos/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/$gkos/time-series/alt_rank.tsv)  
Glaukos Corporation (GKOS) is currently AltRank #1,342 based on combined combined social and market metrics
Daily Average: XXXXX  
X Week: XXXXX +2  
X Month: XXXXX +303  
X Months: XXXXX -XXX  
X Year: XXXXX +815  
1-Year High: XXXXX on 2025-09-13  
1-Year Low: XX on 2024-12-29  
  
  
### Galaxy Score: XXXXX
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$gkos/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/$gkos/time-series/galaxy_score.tsv)  
Current Value: XXXXX  
Daily Average: XX  
X Week: XX -X  
X Month: XX -XX  
X Months: XX +4  
X Year: XX -XX  
1-Year High: XX on 2025-03-03  
1-Year Low: XX on 2025-07-17  
  
  
### Engagements: XXX (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$gkos/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$gkos/time-series/interactions.tsv)  
Current Value: XXX  
Daily Average: XXXXX  
X Week: XXXXXX -XX%  
X Month: XXXXXXX -XX%  
X Months: XXXXXXX +49%  
X Year: XXXXXXX -XX%  
1-Year High: XXXXXX on 2025-10-30  
1-Year Low: XX on 2025-01-30  

Engagements by network (24h):
X: XXX

  
  
### Mentions: XX (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$gkos/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$gkos/time-series/posts_active.tsv)  
Current Value: XX  
Daily Average: XX  
X Week: XX -XX%  
X Month: XXX -XX%  
X Months: XXXXX +74%  
X Year: XXXXX +33%  
1-Year High: XXX on 2025-06-30  
1-Year Low: X on 2025-09-01  

Mentions by network (24h):
X: XX

  
  
### Creators: XX (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$gkos/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$gkos/time-series/contributors_active.tsv)  
XX unique social accounts have posts mentioning Glaukos Corporation (GKOS) in the last XX hours which is down XX% from XX in the previous XX hours
Daily Average: XX  
X Week: XX -XX%  
X Month: XXX -XX%  
X Months: XXXXX +203%  
X Year: XXXXX +130%  
1-Year High: XXX on 2025-06-30  
1-Year Low: X on 2025-09-01  

The most influential creators that mention Glaukos Corporation in the last XX hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@sentantiq](/creator/twitter/sentantiq)             | X    | XXXXXX    | X     | XXX         |
| [@BiopharmIQ](/creator/twitter/BiopharmIQ)           | X    | XXXXXX    | X     | XXX         |
| [@seedytx19](/creator/twitter/seedytx19)             | X    | XXXXX     | X     | XX          |
| [@StockTickerZone](/creator/twitter/StockTickerZone) | X    | XXXXX     | X     | XX          |

[View More](/list/creators/$gkos/100)
  
  
### Sentiment: XX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$gkos/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$gkos/time-series/sentiment.tsv)  
Current Value: XX%  
Daily Average: XX%  
X Week: XX% no change  
X Month: XX% -XX%  
X Months: XX% +15%  
X Year: XX% -XX%  
1-Year High: XXX% on 2025-01-12  
1-Year Low: X% on 2025-09-26  

Most Supportive Themes:
- FDA Approval of Epioxa: (30%) The FDA has approved Glaukos Corporation's Epioxa New Drug Application, a significant development for the company's product pipeline.
- Positive Q3 Financial Results: (25%) Glaukos Corporation reported better-than-expected Q3 financial results, including revenue exceeding estimates and an increase in gross margin.
- Raised FY25 Sales Guidance: (20%) The company has raised its full-year 2025 sales guidance, indicating strong future revenue expectations.
  
Most Critical Themes:
- Market Caution Despite Positive News: (60%) Despite the FDA approval and positive financial results, the market is reacting with caution, leading to lower stock prices.
- Recent Price Drops: (40%) The stock has experienced recent price drops, contributing to a cautious sentiment among investors.
  
  
  
### Social Dominance: XXXXXXX%
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$gkos/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/$gkos/time-series/social_dominance.tsv)  
Current Value: XXXXXXX%  
Daily Average: XXXXXXX%  
X Week: XXXXXXX% +0.00266%  
X Month: XXXXXX% +0.0059%  
X Months: XXXXXX% +0.0037%  
X Year: XXXXXX% +0.0017%  
1-Year High: XXXXX% on 2025-06-30  
1-Year Low: XXXXXX% on 2025-09-01  
  
  
### Market Dominance: XXXXXXX%
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$gkos/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/$gkos/time-series/market_dominance.tsv)  
Current Value: XXXXXXX%  
Daily Average: X%  
1-Year High: XXXXX% on 2025-02-19  
1-Year Low: XXXXXXX% on 2025-12-09  
  
  
### Market Cap: $XXXXXXXXXXXXX
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:$gkos/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/$gkos/time-series/market_cap.tsv)  
Current Value: $XXXXXXXXXXXXX  
Daily Average: $XXXXXXXXXXXXX  
X Week: $XXXXXXXXXXXXX +$0.75%  
X Month: $XXXXXXXXXXXXX +$27%  
X Months: $XXXXXXXXXXXXX +$10%  
X Year: $XXXXXXXXXXXXX -$20%  
1-Year High: $XXXXXXXXXXXXX on 2025-01-23  
1-Year Low: $XXXXXXXXXXXXX on 2025-10-24  

### Top Glaukos Corporation Social Posts
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

""The story of Lykourgos in Diomedes speech is a lesson about angering the gods that Glaukos picks up on and responds to in his own narrative where his Bellerophon becomes hateful to the gods despite performing heroic deeds.""  
[X Link](https://x.com/sentantiq/status/1998042835900391735) [@sentantiq](/creator/x/sentantiq) 2025-12-08T14:51Z 50K followers, 1090 engagements


"In Homer's Iliad and Odyssey: - Achilles: blond hair (xanthos tawny/fair) - Iliad XXXXX XXXXXX - Menelaus: blond hair (xanthos) - Iliad 3.284; bright-eyed (glaukos) - Odysseus: blond hair (xanthos) - Od. 13.399; dark beard; reddish (hyakinthos) - Od. XXXXX - Hector: dark hair - Iliad XXXXXX - Athena: grey/blue-eyed (glaukopis bright/gleaming) - 80+ times - Poseidon: dark hair/eyes - Od. XXX - Demeter: blond (xanthos) - Iliad XXXXX - Aphrodite: golden-haired (xanthos) - Iliad XXXX Sources: Per classical texts; variations in translations exist. (348 chars)"  
[X Link](https://x.com/grok/status/1997894688351846518) [@grok](/creator/x/grok) 2025-12-08T05:03Z 6.8M followers, XX engagements


"1. Diomedes does not know who Glaukos is; Glaukos definitely knows who Diomedes is"  
[X Link](https://x.com/sentantiq/status/1997741671895933152) [@sentantiq](/creator/x/sentantiq) 2025-12-07T18:55Z 50K followers, XXX engagements


"Mind Reading and Stolen Wits: The Encounter of Diomedes and Glaukos in Iliad X SENTENTIAE ANTIQUAE"  
[X Link](https://x.com/rogueclassicist/status/1997741408606925109) [@rogueclassicist](/creator/x/rogueclassicist) 2025-12-07T18:54Z 22.4K followers, XXX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

Glaukos Corporation (GKOS)

Glaukos Corporation's Epioxa receives FDA approval and Q3 earnings beat expectations, but market caution and recent price drops are overshadowing the positive news.

About Glaukos Corporation

Glaukos Corporation is a healthcare company specializing in ophthalmic medical devices and therapies.
Glaukos Corporation uses the ticker $GKOS for trading. Listed in the Stocks category within the Healthcare sectors.

Insights

  • Glaukos Corporation (GKOS) trading volume is up XXXXXX% from the previous week.
  • Glaukos Corporation (GKOS) social dominance is up XXXXXX% from the previous X months.
  • Glaukos Corporation Price hit a 52-Week high of $XXXXXX for the hour
  • Glaukos Corporation Price hit an all time of $XXXXXX for the hour

Price: $XXXXXX

Price Line Chart
Price 24-Hour Time-Series Raw Data
The stock is trading lower due to broader market caution and recent price drops, which are overshadowing positive catalysts like FDA approval and strong Q3 earnings. Analyst upgrades suggest potential upside, but current sentiment is cautious.

24-Hour: -XXXX% 7-Day: XXXX% 30-Day: XXXXX%

1-Year High: $XXXXXX on 2025-01-23
1-Year Low: $XXXXX on 2025-10-24

AltRank: XXXXX

AltRank Line Chart
AltRank 24-Hour Time-Series Raw Data
Glaukos Corporation (GKOS) is currently AltRank #1,342 based on combined combined social and market metrics Daily Average: XXXXX
X Week: XXXXX +2
X Month: XXXXX +303
X Months: XXXXX -XXX
X Year: XXXXX +815
1-Year High: XXXXX on 2025-09-13
1-Year Low: XX on 2024-12-29

Galaxy Score: XXXXX

Galaxy Score Line Chart
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XX
X Week: XX -X
X Month: XX -XX
X Months: XX +4
X Year: XX -XX
1-Year High: XX on 2025-03-03
1-Year Low: XX on 2025-07-17

Engagements: XXX (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XXXXX
X Week: XXXXXX -XX%
X Month: XXXXXXX -XX%
X Months: XXXXXXX +49%
X Year: XXXXXXX -XX%
1-Year High: XXXXXX on 2025-10-30
1-Year Low: XX on 2025-01-30

Engagements by network (24h): X: XXX

Mentions: XX (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
X Week: XX -XX%
X Month: XXX -XX%
X Months: XXXXX +74%
X Year: XXXXX +33%
1-Year High: XXX on 2025-06-30
1-Year Low: X on 2025-09-01

Mentions by network (24h): X: XX

Creators: XX (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning Glaukos Corporation (GKOS) in the last XX hours which is down XX% from XX in the previous XX hours Daily Average: XX
X Week: XX -XX%
X Month: XXX -XX%
X Months: XXXXX +203%
X Year: XXXXX +130%
1-Year High: XXX on 2025-06-30
1-Year Low: X on 2025-09-01

The most influential creators that mention Glaukos Corporation in the last XX hours

Creator Rank Followers Posts Engagements
@sentantiq X XXXXXX X XXX
@BiopharmIQ X XXXXXX X XXX
@seedytx19 X XXXXX X XX
@StockTickerZone X XXXXX X XX

View More

Sentiment: XX%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
X Week: XX% no change
X Month: XX% -XX%
X Months: XX% +15%
X Year: XX% -XX%
1-Year High: XXX% on 2025-01-12
1-Year Low: X% on 2025-09-26

Most Supportive Themes:

  • FDA Approval of Epioxa: (30%) The FDA has approved Glaukos Corporation's Epioxa New Drug Application, a significant development for the company's product pipeline.
  • Positive Q3 Financial Results: (25%) Glaukos Corporation reported better-than-expected Q3 financial results, including revenue exceeding estimates and an increase in gross margin.
  • Raised FY25 Sales Guidance: (20%) The company has raised its full-year 2025 sales guidance, indicating strong future revenue expectations.

Most Critical Themes:

  • Market Caution Despite Positive News: (60%) Despite the FDA approval and positive financial results, the market is reacting with caution, leading to lower stock prices.
  • Recent Price Drops: (40%) The stock has experienced recent price drops, contributing to a cautious sentiment among investors.

Social Dominance: XXXXXXX%

Social Dominance Line Chart
Social Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXX%
Daily Average: XXXXXXX%
X Week: XXXXXXX% +0.00266%
X Month: XXXXXX% +0.0059%
X Months: XXXXXX% +0.0037%
X Year: XXXXXX% +0.0017%
1-Year High: XXXXX% on 2025-06-30
1-Year Low: XXXXXX% on 2025-09-01

Market Dominance: XXXXXXX%

Market Dominance Line Chart
Market Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXX%
Daily Average: X%
1-Year High: XXXXX% on 2025-02-19
1-Year Low: XXXXXXX% on 2025-12-09

Market Cap: $XXXXXXXXXXXXX

Market Cap Line Chart
Market Cap 24-Hour Time-Series Raw Data
Current Value: $XXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXX
X Week: $XXXXXXXXXXXXX +$0.75%
X Month: $XXXXXXXXXXXXX +$27%
X Months: $XXXXXXXXXXXXX +$10%
X Year: $XXXXXXXXXXXXX -$20%
1-Year High: $XXXXXXXXXXXXX on 2025-01-23
1-Year Low: $XXXXXXXXXXXXX on 2025-10-24

Top Glaukos Corporation Social Posts

Top posts by engagements in the last XX hours

Showing only X posts for non-authenticated requests. Use your API key in requests for full results.

""The story of Lykourgos in Diomedes speech is a lesson about angering the gods that Glaukos picks up on and responds to in his own narrative where his Bellerophon becomes hateful to the gods despite performing heroic deeds.""
X Link @sentantiq 2025-12-08T14:51Z 50K followers, 1090 engagements

"In Homer's Iliad and Odyssey: - Achilles: blond hair (xanthos tawny/fair) - Iliad XXXXX XXXXXX - Menelaus: blond hair (xanthos) - Iliad 3.284; bright-eyed (glaukos) - Odysseus: blond hair (xanthos) - Od. 13.399; dark beard; reddish (hyakinthos) - Od. XXXXX - Hector: dark hair - Iliad XXXXXX - Athena: grey/blue-eyed (glaukopis bright/gleaming) - 80+ times - Poseidon: dark hair/eyes - Od. XXX - Demeter: blond (xanthos) - Iliad XXXXX - Aphrodite: golden-haired (xanthos) - Iliad XXXX Sources: Per classical texts; variations in translations exist. (348 chars)"
X Link @grok 2025-12-08T05:03Z 6.8M followers, XX engagements

"1. Diomedes does not know who Glaukos is; Glaukos definitely knows who Diomedes is"
X Link @sentantiq 2025-12-07T18:55Z 50K followers, XXX engagements

"Mind Reading and Stolen Wits: The Encounter of Diomedes and Glaukos in Iliad X SENTENTIAE ANTIQUAE"
X Link @rogueclassicist 2025-12-07T18:54Z 22.4K followers, XXX engagements

Glaukos Corporation (GKOS)
/topic/$gkos